Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Net Income 2010-2024 | MKKGY

Merck annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Merck net income for the quarter ending December 31, 2024 was $0.708B, a 12.42% increase year-over-year.
  • Merck net income for the twelve months ending December 31, 2024 was $3.005B, a 1.68% decline year-over-year.
  • Merck annual net income for 2024 was $3.005B, a 1.68% decline from 2023.
  • Merck annual net income for 2023 was $3.056B, a 12.78% decline from 2022.
  • Merck annual net income for 2022 was $3.504B, a 3.05% decline from 2021.
  
Merck Annual Net Income
(Millions of US $)
2024 $3,005
2023 $3,056
2022 $3,504
2021 $3,614
2020 $2,270
2019 $1,478
2018 $3,985
2017 $2,939
2016 $1,803
2015 $1,237
2014 $1,548
2013 $1,606
2012 $745
2011 $876
2010 $839
2009 $511
Merck Quarterly Net Income
(Millions of US $)
2024-12-31 $708
2024-09-30 $890
2024-06-30 $654
2024-03-31 $753
2023-12-31 $630
2023-09-30 $804
2023-06-30 $768
2023-03-31 $854
2022-12-31 $664
2022-09-30 $930
2022-06-30 $923
2022-03-31 $988
2021-12-31 $919
2021-09-30 $897
2021-06-30 $898
2021-03-31 $901
2020-12-31 $506
2020-09-30 $941
2020-06-30 $319
2020-03-31 $503
2019-12-31 $353
2019-09-30 $381
2019-06-30 $529
2019-03-31 $215
2018-12-31 $2,876
2018-09-30 $395
2018-06-30 $295
2018-03-31 $419
2017-12-31 $1,162
2017-09-30 $758
2017-06-30 $463
2017-03-31 $555
2016-12-31 $288
2016-09-30 $510
2016-06-30 $352
2016-03-31 $652
2015-12-31 $138
2015-09-30 $407
2015-06-30 $380
2015-03-31 $321
2014-12-31 $313
2014-09-30 $331
2014-06-30 $405
2014-03-31 $446
2013-12-31 $382
2013-09-30 $450
2013-06-30 $419
2013-03-31 $345
2012-12-31 $350
2012-09-30 $232
2012-06-30 $-78
2012-03-31 $222
2011-12-31 $178
2011-09-30 $321
2011-06-30 $-124
2011-03-31 $466
2010-12-31 $89
2010-09-30 $272
2010-06-30 $224
2010-03-31 $255
2009-12-31 $82
2009-09-30 $206
2009-06-30 $148
2009-03-31 $75
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.918B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.665B 32.14
Zoetis (ZTS) United States $75.819B 28.29
Daiichi Sankyo, - (DSNKY) Japan $49.559B 25.21
Takeda Pharmaceutical (TAK) Japan $47.633B 9.47
Sandoz Group AG (SDZNY) Switzerland $22.493B 0.00
Summit Therapeutics (SMMT) United States $15.314B 0.00
United Therapeutics (UTHR) United States $14.624B 12.94
Shionogi (SGIOY) Japan $14.121B 14.15
Neurocrine Biosciences (NBIX) United States $12.371B 42.37
Orion OYJ (ORINY) Finland $9.913B 26.81
IPSEN (IPSEY) France $9.890B 0.00
Corcept Therapeutics (CORT) United States $7.371B 59.92
Stevanato Group S.p.A (STVN) Italy $6.599B 40.35
Madrigal Pharmaceuticals (MDGL) United States $6.315B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.734B 0.00
Ionis Pharmaceuticals (IONS) United States $5.532B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.900B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.038B 10.65
Crinetics Pharmaceuticals (CRNX) United States $3.006B 0.00
Hypermarcas (HYPMY) Brazil $2.829B 18.61
BioCryst Pharmaceuticals (BCRX) United States $2.342B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.335B 12.63
NewAmsterdam Pharma (NAMS) Netherlands $2.098B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.785B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.784B 0.00
Indivior (INDV) United States $1.748B 7.41
Dyne Therapeutics (DYN) United States $1.508B 0.00
Evotec AG (EVO) Germany $1.431B 0.00
ARS Pharmaceuticals (SPRY) United States $1.427B 0.00
Guardian Pharmacy Services (GRDN) United States $1.380B 0.00
Ocular Therapeutix (OCUL) United States $1.327B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.081B 21.62
Harrow (HROW) United States $1.076B 0.00
Enliven Therapeutics (ELVN) United States $1.073B 0.00
Ardelyx (ARDX) United States $0.940B 0.00
Collegium Pharmaceutical (COLL) United States $0.939B 5.07
Avadel Pharmaceuticals (AVDL) Ireland $0.912B 0.00
Akebia Therapeutics (AKBA) United States $0.898B 0.00
Cronos Group (CRON) Canada $0.744B 0.00
Xeris Biopharma Holdings (XERS) United States $0.727B 0.00
KalVista Pharmaceuticals (KALV) United States $0.664B 0.00
Xencor (XNCR) United States $0.651B 0.00
AleAnna (ANNA) United States $0.631B 0.00
Elite Pharmaceuticals (ELTP) United States $0.577B 0.00
Relay Therapeutics (RLAY) United States $0.564B 0.00
Theravance Biopharma (TBPH) United States $0.556B 0.00
USANA Health Sciences (USNA) United States $0.556B 12.09
Regulus Therapeutics (RGLS) United States $0.552B 0.00
Bioventus (BVS) United States $0.547B 13.88
Zevra Therapeutics (ZVRA) United States $0.485B 0.00
Tourmaline Bio (TRML) United States $0.474B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.456B 0.00
Oruka Therapeutics (ORKA) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.443B 9.25
Altimmune (ALT) United States $0.440B 0.00
Verve Therapeutics (VERV) United States $0.431B 0.00
Savara (SVRA) United States $0.415B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.364B 9.85
Organogenesis (ORGO) United States $0.356B 0.00
Aquestive Therapeutics (AQST) United States $0.316B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.296B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.86
MediWound (MDWD) Israel $0.233B 0.00
ProKidney (PROK) United States $0.228B 0.00
Esperion Therapeutics (ESPR) United States $0.208B 0.00
Nanobiotix S.A (NBTX) France $0.193B 0.00
4D Molecular Therapeutics (FDMT) United States $0.179B 0.00
Journey Medical (DERM) United States $0.168B 0.00
OmniAb (OABI) United States $0.167B 0.00
Profound Medical (PROF) Canada $0.165B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Avita Medical (RCEL) United States $0.155B 0.00
Larimar Therapeutics (LRMR) United States $0.154B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.151B 0.00
Achieve Life Sciences (ACHV) Canada $0.146B 0.00
Aldeyra Therapeutics (ALDX) United States $0.141B 0.00
Nektar Therapeutics (NKTR) United States $0.139B 0.00
Liminatus Pharma (LIMN) $0.138B 0.00
Wellgistics Health (WGRX) United States $0.134B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.118B 0.00
Korro Bio (KRRO) United States $0.112B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.092B 0.00
Champions Oncology (CSBR) United States $0.089B 14.61
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 64.22
Nutriband (NTRB) United States $0.086B 0.00
Pyxis Oncology (PYXS) United States $0.082B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Metagenomi (MGX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Dominari Holdings (DOMH) United States $0.064B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.048B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Lyra Therapeutics (LYRA) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.14
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
SHINECO (SISI) China $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00